Company / R&D Expense
INVO Fertility, Inc. R&D Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$4.9K
FY2025
5-year range
$4.9K / $544.0K
FY2021-FY2025
Trend
-97.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 6 years, ranging from $0 in FY2020 to $544,043 in FY2023.
Based on SEC 10-K filings.
$4,880 in FY2025 with a 3-year CAGR of -71.7%.
Declined from $544,043 to $4,880 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -71.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -71.7%, indicating a declining trend.
- In FY2025, r&d expense decreased 97.1% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.9K | -97.1% |
| FY2024 | $165.9K | -69.5% |
| FY2023 | $544.0K | +151.4% |
| FY2022 | $216.4K | -45.7% |
| FY2021 | $398.4K | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026